BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 26162500)

  • 1. Tetra-triethyleneoxysulfonyl substituted zinc phthalocyanine for photodynamic cancer therapy.
    Kuzyniak W; Ermilov EA; Atilla D; Gürek AG; Nitzsche B; Derkow K; Hoffmann B; Steinemann G; Ahsen V; Höpfner M
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():148-157. PubMed ID: 26162500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel zinc phthalocyanine as a promising photosensitizer for photodynamic treatment of esophageal cancer.
    Kuzyniak W; Schmidt J; Glac W; Berkholz J; Steinemann G; Hoffmann B; Ermilov EA; Gürek AG; Ahsen V; Nitzsche B; Höpfner M
    Int J Oncol; 2017 Mar; 50(3):953-963. PubMed ID: 28098886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy of hepatocellular carcinoma using tetra-triethyleneoxysulfonyl zinc phthalocyanine as photosensitizer.
    Ogbodu RO; Nitzsche B; Ma A; Atilla D; Gürek AG; Höpfner M
    J Photochem Photobiol B; 2020 Jul; 208():111915. PubMed ID: 32480203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro photodynamic activities of zinc(II) phthalocyanines substituted with pyridine moieties.
    Liu JY; Li J; Yuan X; Wang WM; Xue JP
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():341-343. PubMed ID: 26192694
    [No Abstract]   [Full Text] [Related]  

  • 5. Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy.
    Dias LM; Sharifi F; de Keijzer MJ; Mesquita B; Desclos E; Kochan JA; de Klerk DJ; Ernst D; de Haan LR; Franchi LP; van Wijk AC; Scutigliani EM; Cavaco JEB; Tedesco AC; Huang X; Pan W; Ding B; Krawczyk PM; Heger M;
    J Photochem Photobiol B; 2021 Mar; 216():112146. PubMed ID: 33601256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylsulfonyl Zn phthalocyanine: A polyvalent and powerful hydrophobic photosensitizer with a wide spectrum of photodynamic applications.
    İşci Ü; Beyreis M; Tortik N; Topal SZ; Glueck M; Ahsen V; Dumoulin F; Kiesslich T; Plaetzer K
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():40-47. PubMed ID: 26529064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel zinc‑ and silicon‑phthalocyanines as photosensitizers for photodynamic therapy of cholangiocarcinoma.
    Schmidt J; Kuzyniak W; Berkholz J; Steinemann G; Ogbodu R; Hoffmann B; Nouailles G; Gürek AG; Nitzsche B; Höpfner M
    Int J Mol Med; 2018 Jul; 42(1):534-546. PubMed ID: 29693115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vitro proof-of-concept of interstitially targeted zinc- phthalocyanine liposomes for photodynamic therapy.
    Broekgaarden M; de Kroon AI; Gulik TM; Heger M
    Curr Med Chem; 2014; 21(3):377-91. PubMed ID: 23931271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and phototherapeutic properties of Zinc (II) 2,9,16,23-tetrakis (methoxy) phthalocyanine in vivo.
    Yslas EI; Prucca C; Romanini S; Durantini EN; Bertuzzi M; Rivarola V
    Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):62-70. PubMed ID: 19447373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of phthalocyanine conjugates with gold nanoparticles and liposomes for photodynamic therapy.
    Nombona N; Maduray K; Antunes E; Karsten A; Nyokong T
    J Photochem Photobiol B; 2012 Feb; 107():35-44. PubMed ID: 22209036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells.
    da Volta Soares M; Oliveira MR; dos Santos EP; de Brito Gitirana L; Barbosa GM; Quaresma CH; Ricci-Júnior E
    Int J Nanomedicine; 2011; 6():227-38. PubMed ID: 21499420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid Liquid Crystal Nanocarriers for Enhanced Zinc Phthalocyanine-Mediated Photodynamic Therapy.
    Nag OK; Naciri J; Erickson JS; Oh E; Delehanty JB
    Bioconjug Chem; 2018 Aug; 29(8):2701-2714. PubMed ID: 29990422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular uptake and fluorescence imaging potential in tumor cell of zinc phthalocyanine.
    Avşar G; Sari FA; Yuzer AC; Soylu HM; Er O; Ince M; Lambrecht FY
    Int J Pharm; 2016 May; 505(1-2):369-75. PubMed ID: 27085647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity.
    Xu P; Chen J; Chen Z; Zhou S; Hu P; Chen X; Huang M
    PLoS One; 2012; 7(5):e37051. PubMed ID: 22693566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-Infrared Activatable Phthalocyanine-Poly-L-Glutamic Acid Conjugate: Enhanced in Vivo Safety and Antitumor Efficacy toward an Effective Photodynamic Cancer Therapy.
    Cheah HY; Gallon E; Dumoulin F; Hoe SZ; Japundžić-Žigon N; Glumac S; Lee HB; Anand P; Chung LY; Vicent MJ; Kiew LV
    Mol Pharm; 2018 Jul; 15(7):2594-2605. PubMed ID: 29763568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
    Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
    J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monomer zinc phthalocyanine/upconversion nanoparticle coated with hyaluronic acid crosslinked gel as NIR light-activated drug for in vitro photodynamic therapy.
    Zhou L; Chen E; Jin W; Wang Y; Zhou J; Wei S
    Dalton Trans; 2016 Sep; 45(38):15170-15179. PubMed ID: 27711660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the stabilization of zinc phthalocyanine in sol-gel TiO2 for photodynamic therapy applications.
    Lopez T; Ortiz E; Alvarez M; Navarrete J; Odriozola JA; Martinez-Ortega F; Páez-Mozo EA; Escobar P; Espinoza KA; Rivero IA
    Nanomedicine; 2010 Dec; 6(6):777-85. PubMed ID: 20493967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy using zinc phthalocyanine with low dose of diode laser combined with doxorubicin is a synergistic combination therapy for human SK-MEL-3 melanoma cells.
    Doustvandi MA; Mohammadnejad F; Mansoori B; Tajalli H; Mohammadi A; Mokhtarzadeh A; Baghbani E; Khaze V; Hajiasgharzadeh K; Moghaddam MM; Hamblin MR; Baradaran B
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():88-97. PubMed ID: 31454716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of in vitro PDT activities of zinc phthalocyanine immobilised TiO
    Yurt F; Ince M; Colak SG; Ocakoglu K; Er O; Soylu HM; Gunduz C; Avci CB; Kurt CC
    Int J Pharm; 2017 May; 524(1-2):467-474. PubMed ID: 28365390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.